REGISTERED NUMBER: 04794962 (England and Wales)

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

IBA MOLECULAR UK LIMITED

Page

Balance Sheet

1

Notes to the Financial Statements

2

Current assets

Debtors: amounts falling due within one year

4

4,132,240

386,993

Debtors: amounts falling due after more than one year

4

527

4,697,773

Cash in hand

13,754

16,139

4,146,521

5,100,905

Creditors

Amounts falling due within one year

5

29,719

27,001

Net current assets

4,116,802

5,073,904

Total assets less current liabilities

4,116,802

5,073,904

Provisions for liabilities

6

-

913,316

Net assets

4,116,802

4,160,588

Capital and reserves

Called up share capital

7

23,173,157

23,173,157

Retained earnings

8

(19,056,355

)

(19,012,569

)

Shareholders' funds

4,116,802

4,160,588

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 September 2025 and were signed by:

X Defourt - Director

1.	Statutory information

IBA Molecular UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

04794962

Registered office:

Belmont House

Station Way

Crawley

West Sussex

RH10 1JA

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Decommissioning provision

A decommissioning provision is recognised when a site is constructed to provide for the expected costs payable to decommission it in accordance with the lease agreements and local regulatory requirements.

The provisions are calculated by management with reference to the work of external experts in the field and are discounted to reflect the time value of money where this is material.

Going concern

The accounts have been prepared on the Going Concern basis as the Directors are of the opinion that the company has funding arrangements in place that are sufficient for its foreseeable requirements and that all liabilities can be met as they fall due.

3.	Employees and directors

The average number of employees during the year was NIL (2023 - NIL).

4.

Debtors

31.12.24

31.12.23

£

£

Amounts falling due within one year:

Trade debtors

310

310

Other debtors

4,131,930

386,683

4,132,240

386,993

Amounts falling due after more than one year:

Other debtors

527

4,697,773

Aggregate amounts

4,132,767

5,084,766

5.

Creditors: amounts falling due within one year

31.12.24

31.12.23

£

£

Trade creditors

4,770

1,470

Taxation and social security

-

982

Other creditors

24,949

24,549

29,719

27,001

6.	Provisions for liabilities

During the year ended 31 December 2024, the company released its provision of £742,672 previously recognised in respect of Unit 19 Quadrum Park, Guildford, decommissioning costs for equipment following a release of its legal obligations. As a result of this release, the company is no longer legally or constructively obligated to undertake decommissioning or restoration activities related to this asset. Accordingly, the provision was derecognised and the corresponding balance within debtors falling due in more than one year was also released. There was no impact to the loss for the financial year. The debtor was historically held as this equipment was no longer owned by IBA Molecular UK Limited and agreements were in place such that these costs will be borne by the current owners of the equipment.

7.	Called up share capital

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.24

31.12.23

value:

£

£

23,173,157

Ordinary

£1

23,173,157

23,173,157

The shares have attached to them full voting, divided ad capital distribution rights.

8.

Reserves

Retained

earnings

£

At 1 January 2024

(19,012,569

)

Deficit for the year

(43,786

)

At 31 December 2024

(19,056,355

)

Share Capital

Share capital represents the nominal value of equity shares.

Retained earnings

Retained earnings include all current and prior period retained profits and losses.

9.	Disclosure under Section 444(5B) of the Companies Act 2006

The Report of the Auditors was unqualified.

Amit Prasanna (Senior Statutory Auditor)

for and on behalf of Rock Tax & Accounting

10.	Related party disclosures

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

11.	Ultimate controlling party

The company is a wholly owned subsidiary of Curium International SA, a company incorporated in Belgium. The ultimate holding company is GLO Healthcare S.C.A., a company incorporated in Luxembourg.

The smallest group for which consolidated accounts are prepared is Bidco S.à.r.l., with registered office at 13, rue Aldringen, L-1118 Luxembourg, Grand Duchy of Luxembourg.